Biosergen AB (publ) (STO:BIOSGN)

Sweden flag Sweden · Delayed Price · Currency is SEK
37.00
-1.00 (-2.63%)
Mar 9, 2026, 2:38 PM CET
-13.55%
Market Cap 86.88M
Revenue (ttm) n/a
Net Income (ttm) -40.82M
Shares Out 2.35M
EPS (ttm) -17.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 177
Average Volume 1,301
Open 37.20
Previous Close 38.00
Day's Range 37.00 - 38.40
52-Week Range 28.10 - 67.80
Beta 0.29
RSI 33.27
Earnings Date May 6, 2026

About Biosergen AB

Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1
Stock Exchange Nasdaq Stockholm
Ticker Symbol BIOSGN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.